Related Experiment Videos
Thyroid eye disease--medical or surgical therapy?
1Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur.
Annals of the Academy of Medicine, Singapore
|March 1, 1991
Summary
Thyroid eye disease, an autoimmune condition often linked to Graves' disease, presents varied symptoms. Current treatments range from conservative eye drops to surgical interventions, with immunosuppressants like cyclosporin A showing mixed results.
Area of Science:
- Ophthalmology
- Immunology
- Endocrinology
Background:
- Thyroid eye disease (TED) is an autoimmune disorder frequently associated with Graves' disease.
- Pathological mechanisms involve autoantibodies targeting eye muscle membranes and antibody-dependent cell-mediated cytotoxicity.
- TED commonly manifests as proptosis, eyelid abnormalities, and potentially vision-threatening complications.
Purpose of the Study:
- To review current treatment modalities for thyroid eye disease.
- To present the authors' clinical experience utilizing cyclosporin A for TED management.
Main Methods:
- Review of existing literature on TED treatments.
- Clinical case series evaluating cyclosporin A efficacy in patients with thyroid eye disease.
Main Results:
- Mild TED cases are managed conservatively with eye drops.
- Severe proptosis may require lateral tarsorrhaphy, special lenses, or surgical muscle correction.
- Management of severe TED with high intraocular pressure or risk of blindness involves controversial options like surgical decompression or high-dose prednisolone, with variable success for immunosuppressive therapies including cyclosporin A.
Conclusions:
- Treatment strategies for thyroid eye disease are tailored to symptom severity.
- Cyclosporin A demonstrated inconclusive results in the authors' experience, warranting further investigation into immunomodulatory therapies for TED.